• Trendspotting: Artificial Intelligence, Impact of Global Policies, Data Harmonization

    Bio-IT World | To kick off 2026, we spoke with industry experts and leaders in the Bio-IT World community about what they expect and look forward to in the new year. Here are the full trends and predictions, including more on AI, drug development, global policies, cancer treatments, and more.

    Jan 6, 2026

  • Top Stories of 2025: AI for Research, Innovative Practices, Digital Twins

    Bio-IT World | In the Bio-IT World year, focus continues to be paid to pharma’s research choices and the latest in sequencing technologies. AI models for protein structure prediction have had a good year, and natural materials, psilocybin in particular, have garnered attention.

    Dec 29, 2025

  • Follow the Money: Molecular Glue Degrader, Physical AI Scientists, TNF Programs

    Bio-IT World | TRIANA will continue development of their molecular glue degrader to clinical proof; Medra’s Physical AI autonomously allows scientists to adapt workflows through natural-language instructions; PsiThera will advance their Tumor Necrosis Factor superfamily preclinical programs; and more.

    Dec 23, 2025

  • Thermo Fisher’s New Devices, LabGenius, Sanofi Collaboration, Singapore-MIT Alliance Launches New Project

    Bio-IT World | Thermo Fisher Scientific has introduced the Thermo Scientific X and S Series Centrifuges; LabGenius has entered a second collaboration with Sanofi; the Singapore-MIT Alliance for Research and Technology has launched a new collaborative research project; and more.

    Dec 22, 2025

  • Scientists Discover Allergy-Triggering Role of Peptide in the Gut

    Bio-IT World | It has been firmly established in recent years that regulation of the intestinal epithelium relies heavily on signaling from epithelial, stromal, and immune cells. But there’s also a fourth player, a “very important peptide” known as VIP, which acts directly on stem cells in the gut to restrain an allergy-like response, according to Manuel Jakob, M.D., a clinician-scientist and abdominal surgeon based in Bern, Switzerland and a Ph.D. candidate at Charité -- Universitätsmedizin Berlin.

    Dec 18, 2025

  • Caris Life Sciences, Genentech Announce Oncology Collaboration Worth $1.1 Billion

    Bio-IT World | Caris Life Sciences yesterday announced that its therapeutic research arm, Caris Discovery, has entered into a multi-year collaboration and license agreement with Genentech, a member of the Roche Group.

    Dec 17, 2025

  • Protein Signature Linked to Death Risk Could Aid Life Extension Efforts

    Bio-IT World | A biological signal of death can be found in the blood five to 10 years in advance of that mortality outcome, a fascinating and unexpected discovery made in the quest for a signature marker of multi-morbidity by researchers at the University of Surry (UK). While by no means a clinically validated predictive test, the protein panels hold promise in motivating lifestyle changes and food choices that could change that poor health trajectory.

    Dec 16, 2025

  • Modeling and Shared Compute Reveals Pathways of Synthetic Drug

    Bio-IT World | Researchers from the University of Illinois Urbana-Champaign used deep learning and large-scale computer simulations to identify structural differences in synthetic cannabinoid molecules that cause them to bind to human brain receptors differently from classical cannabinoids.

    Dec 12, 2025

  • Rethinking Precision Oncology in the Age of Functional Data

    Bio-IT World | Historically, cancer treatment has relied on a one-size-fits-all approach known as the Standard of Care, where patients are treated based on population averages. But cancer is not a single disease; it’s thousands of distinct conditions, each driven by unique biology.

    Dec 11, 2025